1335027-51-4

Basic information

• Product Name: ethyl 3-cyclobutyl-2-[(3,4-dichlorophenyl)methyl]-3-oxopropanoate
• Synonyms: ethyl 3-cyclobutyl-2-[(3,4-dichlorophenyl)methyl]-3-oxopropanoate
• CAS NO: 1335027-51-4
• Molecular Weight: 329.223
• Mol File: 1335027-51-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 3-cyclobutyl-2-[(3,4-dichlorophenyl)methyl]-3-oxopropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-cyclobutyl-2-[(3,4-dichlorophenyl)methyl]-3-oxopropanoate(1335027-51-4)
• EPA Substance Registry System: ethyl 3-cyclobutyl-2-[(3,4-dichlorophenyl)methyl]-3-oxopropanoate(1335027-51-4)

Safety Data

• Hazardous Substances Data: 1335027-51-4(Hazardous Substances Data)

Upstream product

• 24922-01-8 ethyl 3-cyclobutyl-3-oxopropanoate 
• 18880-04-1 3,4-dichlorobenzyl bromide 

Downstream Products

• 1335026-54-4 5-cyclobutyl-6-[(3,4-dichlorophenyl)methyl]-4H-[1,2,4]triazolo[5,1-b]pyrimidin-7-one 

Relevant articles and documents

7-HYDROXY-PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS

The compounds of formula (I) are antagonists of the CCR2 receptor Wherein R1-7 and A are as defined in the claims.

4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS

The present invention relates to novel compounds for use in the compositions, to processes for their preparation, to intermediates useful in their preparation and to their use as therapeutic agents. The present invention also relates to pharmaceutical com